When the pandemic turned our world upside down, you didn't retreat — you took action.
By donating to COVID-19 research at Fred Hutch, you became part of an extraordinary scientific sprint to understand and overcome the novel coronavirus. Whether you gave $20 or $20,000 — or more — you empowered our scientists to quickly turn to face the crisis, using expertise built, in part, through decades of philanthropic support for basic science and infectious disease research.
We are grateful to you for your belief in fearless science, your instinct to act, and your generous support. And we’re proud to share highlights of progress your generous support has made possible.
Philanthropic donors jump-started our COVID-19 research before large funding agencies were able to mobilize. And you’ve enabled us to maintain our momentum every step of the way. Our researchers have played a pivotal role in the international scientific response to the pandemic, thanks to you.
Your support for COVID-19 research has allowed our scientists to formidable challenges at record speed. Highlights include:
Your gift makes it possible to test outside-the-box ideas that are not yet ready for foundation or government funding. Donor-funded pilot awards allow scientists to generate the proof of concept they need to attract larger grants — and they are critical to jump-starting the most innovative projects. Thanks to you, the investigators listed below have received donor-funded COVID-19 pilot awards.
Research Associate, Vaccine and Infectious Diseases Division
Dr. Boonyaratanakornkit in the Taylor Lab is investigating how cells that have previously produced antibodies in response to common cold-causing coronaviruses influence infection by the pandemic-causing SARS-CoV-2 virus. His goal is to design 2-for-1 strategies that can protect people from both types of coronaviruses.
Assistant Professor, Clinical Research Division
Dr. Dey’s project is a “fail fast” study of whether it might be possible to target the microbiome to help patients recover more quickly or reduce the virus's chance of spreading through fecal transmission.
Assistant Professor, Human Biology Division
Dr. Gujral is employing new machine-learning methods to learn how the coronavirus causes immune cells to trigger “cytokine storms,” the cause of respiratory failure in severe cases in COVID-19, and to pinpoint potential treatments.
Assistant Professor, Public Health Sciences Division
Dr. Ko is leveraging her long-standing research partnerships with community-based organizations to evaluate the impact of COVID-19 on their ability to deliver lifeline services to older adults in the Asian American and Pacific Islander community. This project, which aims to inform strategies to improve health equity, is funded by the Vadon Foundation.
Principal Staff Scientist, Vaccine and Infectious Disease Division
Dr. Kublin’s team is studying microbes in the gut and respiratory tract of COVID-19 patients to look for a correlation between patients’ microbiomes and their clinical outcomes.
We’ve been amazed and impressed by the inventive ways people are using their unique skills and interests to work fuel COVID-19 research — all while sheltering at home. Here are a few examples: